Thomas Caffrey

About Thomas Caffrey

Thomas Caffrey, With an exceptional h-index of 26 and a recent h-index of 17 (since 2020), a distinguished researcher at University of Nebraska Medical Center, specializes in the field of Pancreatic cancer, Cancer Autopsy, Pathology, Patient derived Models, IgE Therapeutics.

His recent articles reflect a diverse array of research interests and contributions to the field:

Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9. 6

Uncovering Tumor‐Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma

Method development for generation of PDX models from rapid autopsy samples for the NCI patient-derived models repository

Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling

IgE-based therapeutic combination enhances antitumor response in preclinical models of pancreatic cancer

654 Analysis of IDO-1 expression on dendritic cells and factors influencing its up-and downregulation in pancreatic cancer

MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans

Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer

Thomas Caffrey Information

University

Position

Cancer Researcher; Eppley Institute Buffett Cancer Center

Citations(all)

3454

Citations(since 2020)

1704

Cited By

2142

hIndex(all)

26

hIndex(since 2020)

17

i10Index(all)

35

i10Index(since 2020)

27

Email

University Profile Page

Google Scholar

Thomas Caffrey Skills & Research Interests

Pancreatic cancer

Cancer Autopsy

Pathology

Patient derived Models

IgE Therapeutics

Top articles of Thomas Caffrey

Structural Basis for Multivalent MUC16 Recognition and Robust Anti-Pancreatic Cancer Activity of Humanized Antibody AR9. 6

Molecular Cancer Therapeutics

2024/2/23

Uncovering Tumor‐Promoting Roles of Activin A in Pancreatic Ductal Adenocarcinoma

Advanced Science

2023/6

Method development for generation of PDX models from rapid autopsy samples for the NCI patient-derived models repository

Cancer Research

2022/6/15

Visceral adipose tissue remodeling in pancreatic ductal adenocarcinoma cachexia: the role of activin A signaling

Scientific reports

2022/1/31

IgE-based therapeutic combination enhances antitumor response in preclinical models of pancreatic cancer

Molecular cancer therapeutics

2021/12/1

654 Analysis of IDO-1 expression on dendritic cells and factors influencing its up-and downregulation in pancreatic cancer

2021/11/1

MUC4 enhances gemcitabine resistance and malignant behaviour in pancreatic cancer cells expressing cancer-associated short O-glycans

Cancer letters

2021/4/10

Isoforms of MUC16 activate oncogenic signaling through EGF receptors to enhance the progression of pancreatic cancer

Molecular Therapy

2021/4/7

Inhibition of the receptor for advanced glycation End products enhances the cytotoxic effect of gemcitabine in murine pancreatic tumors

Biomolecules

2021/4/1

Metabolic programming of distinct cancer stem cells promotes metastasis of pancreatic ductal adenocarcinoma

Oncogene

2021/1/7

Development of a MUC16-targeted near-infrared fluorescent antibody conjugate for intraoperative imaging of pancreatic cancer

Molecular cancer therapeutics

2020/8/1

Abstract PR15: A novel NK cell-targeted therapeutic strategy against pancreatic cancer

Cancer Immunology Research

2020/4/1

The proteomic landscape of pancreatic ductal adenocarcinoma liver metastases identifies molecular subtypes and associations with clinical response

Clinical Cancer Research: an Official Journal of the American Association for Cancer Research

2021/7/1

MUC16 as a potential target for the surgical detection of pancreatic cancer

2020/2/19

See List of Professors in Thomas Caffrey University(University of Nebraska Medical Center)

Co-Authors

academic-engine